4.2100
-0.0200
(-0.47%)
At close: January 10 at 4:00:01 PM EST
4.4100
+0.20
+(4.75%)
After hours: 7:38:51 PM EST
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 4 | 4 |
| Avg. Estimate | -0.12 | -0.16 | 0.88 | -0.45 |
| Low Estimate | -0.12 | -0.16 | 0.74 | -0.54 |
| High Estimate | -0.12 | -0.16 | 1.15 | -0.32 |
| Year Ago EPS | -0.39 | -0.31 | -1.18 | 0.88 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 2 | 5 | 6 |
| Avg. Estimate | 6.5M | 13.56M | 530.38M | 73.75M |
| Low Estimate | -- | -- | 520.7M | -- |
| High Estimate | 15.8M | 27.11M | 543.1M | 154.78M |
| Year Ago Sales | 22.6M | 12.37M | 53.8M | 530.38M |
| Sales Growth (year/est) | -71.24% | 9.57% | 885.84% | -86.09% |
Earnings History
| Currency in EUR | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.21 | -0.26 | 1.41 |
| EPS Actual | -0.39 | -0.31 | -0.32 | 1.5 |
| Difference | -0.25 | -0.1 | -0.06 | 0.09 |
| Surprise % | -186.49% | -47.60% | -22.53% | 6.02% |
EPS Trend
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.12 | -0.16 | 0.88 | -0.51 |
| 7 Days Ago | -0.18 | -0.16 | 0.23 | -0.45 |
| 30 Days Ago | -0.18 | -0.16 | -0.2 | -0.55 |
| 60 Days Ago | -0.18 | -0.16 | -0.2 | -0.55 |
| 90 Days Ago | -0.18 | -0.16 | -0.19 | -0.62 |
EPS Revisions
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | -- |
| Up Last 30 Days | 1 | 1 | 2 | -- |
| Down Last 7 Days | -- | -- | -- | 2 |
| Down Last 30 Days | -- | -- | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVAC | 69.23% | 47.99% | 174.48% | -150.80% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 9/16/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/16/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 7/3/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 4/25/2024 |
| Reiterates | Guggenheim: Neutral | 4/5/2024 |
| Initiated | Guggenheim: Buy | 4/26/2021 |
Related Tickers
NVAX Novavax, Inc.
9.32
-3.02%
BNTX BioNTech SE
122.85
+0.57%
VIR Vir Biotechnology, Inc.
12.10
-3.04%
MRNA Moderna, Inc.
42.25
-2.13%
INO Inovio Pharmaceuticals, Inc.
1.9800
-5.26%
VXRT Vaxart, Inc.
0.7898
-2.42%
IMRX Immuneering Corporation
2.0700
+3.50%
HOTH Hoth Therapeutics, Inc.
1.9000
0.00%
ABSI Absci Corporation
2.8550
-11.34%
NMRA Neumora Therapeutics, Inc.
2.2100
-6.75%